Mubadala acquires majority stakes in Global Medical Supply Chain and Al Ittihad Drug Store
Abu Dhabi- December 2024- Mubadala Investment Company PJSC “Mubadala” has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store... Read more.
Emirates Drug Establishment reviews key achievements and future plans
UAE- December 2024 – The Board of Directors of the Emirates Drug Establishment (EDE) has wrapped up its annual meetings for 2024 with a session outlining this... Read more.
Hamad Medical Corporation wins CIPD Middle East award for best wellbeing program
Doha, Qatar- 24 December 2024: Hamad Medical Corporation’s Human Resources Department has been honoured with the Best Wellbeing Program Award at the CIPD Middle... Read more.
Sidra Medicine performs Qatar’s first C-Section in angiography suite
December 2024- Doha, Qatar- Sidra Medicine has become the first hospital in the region to successfully perform a high-risk cesarean section (C-section) in its state-of-the-art... Read more.
DHA highlights AI drive and diagnostic advancements in healthcare
Dubai, UAE- December 2024- The Dubai Health Authority (DHA), in collaboration with Roche Diagnostics Middle East, hosted a one-day workshop titled “NABIDH Elevate”,... Read more.
MoHAP launches National School Health Screening guideline
UAE- December 2024- The Ministry of Health and Prevention (MoHAP) UAE has launched the National School Health Screening Guideline in partnership with health, education,... Read more.
AbbVie acquires Nimble Therapeutics to advance autoimmune and psoriasis treatments
December 2024- AbbVie and Nimble Therapeutics announced a definitive agreement under which AbbVie will acquire Nimble, including its lead asset, an investigational... Read more.
Yemen reports the highest burden of cholera globally
Aden, Yemen- 23 December 2024- Yemen bears the highest burden of cholera globally. The country has experienced persistent cholera transmission for many years, including... Read more.
Gene Therapy for Children: A Conversation with Prof. Stephan Grupp | Dr. Zainul Aabideen | EPBMT2024
In this insightful interview, Dr. Zainul Aabideen speaks with Prof. Stephan Grupp, a leading expert in pediatric oncology and gene therapy at the Children’s... Read more.
Sanofi begins Phase 3 trials for PCV21, expands SK Bioscience partnership
Paris- 23 December 2024- Sanofi and SK bioscience have entered into a new chapter of their collaboration in pneumococcal vaccines with an expanded agreement to develop,... Read more.
